Disc Medicine (IRON) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.73% |
| Dec 31, 2025 | 9.41% |
| Sep 30, 2025 | 0.25% |
| Jun 30, 2025 | -15.81% |
| Mar 31, 2025 | -50.06% |
| Dec 31, 2024 | -58.82% |
| Sep 30, 2024 | -12.79% |
| Jun 30, 2024 | 54.19% |
| Mar 31, 2024 | -88.80% |
| Dec 31, 2023 | -138.04% |
| Sep 30, 2023 | 41.24% |
| Jun 30, 2023 | 64.12% |
| Mar 31, 2023 | -266.95% |
| Dec 31, 2022 | 0.28% |
| Sep 30, 2022 | -5.42% |
| Jun 30, 2022 | 32.90% |
| Mar 31, 2022 | -170.27% |
| Dec 31, 2021 | 221.13% |
| Sep 30, 2021 | -1.06% |
| Jun 30, 2021 | -6.14% |
| Mar 31, 2021 | -3,503.89% |
| Dec 31, 2020 | -118.51% |
| Sep 30, 2020 | 97.29% |
| Jun 30, 2020 | 28.82% |